New Jersey § 24:6a-1

§ 24:6a-1.

a. No person shall introduce or deliver for introduction into intrastate commerce

in the State of New Jersey any new drug unless (1) an application with respect thereto

has become effective under the Federal Act, 1 or (2) an application filed pursuant to subsection b is effective with respect to

such drug. b. Any person may file with the Department of Health of the State of New Jersey an

application with respect to any new drug subject to the provisions of subsection a. Such person shall submit to the Department of Health of the State of New Jersey

as a part of the application (1) full reports of investigations which have been made

to show whether or not such drug is safe for use; (2) a full list of the articles

used as components of such drug; (3) a full statement of the composition of such

drug; (4) a full description of the methods used in, and the facilities and controls

used for, the manufacture, processing and packing of such drug; (5) such samples

of such drug and of the articles used as components thereof as the Department of Health

of the State of New Jersey may require; and (6) specimens of the labeling proposed

to be used for such drug. c. The application provided for in subsection b shall become effective on the sixtieth

day after the filing thereof unless prior to such day the Department of Health of

the State of New Jersey by notice to the applicant in writing postpones the effective

date of the application to such time (not more than one hundred eighty days after

the filing thereof) as the Department of Health of the State of New Jersey deems necessary

to enable it to study and investigate the application. d. If the Department of Health of the State of New Jersey finds, after due notice

to the applicant and giving him an opportunity for a hearing that (1) the investigations,

reports of which are required to be submitted to the Department of Health of the State

of New Jersey pursuant to subsection b, do not include adequate tests by all methods

reasonably applicable to show whether or not such drug is safe for use under the conditions

prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results

of such tests show that such drug is unsafe for use under such conditions or do not

show that such drug is safe for use under such conditions; (3) the methods used in,

and the facilities and controls used for, the manufacture, processing, and packing

of such drug, are inadequate to preserve its identity, strength, quality, and purity;

or (4) upon the basis of the information submitted to the Department of Health of

the State of New Jersey as part of the application, or upon the basis of any other

information before the Department of Health of the State of New Jersey with respect

to such drug, the Department of Health of the State of New Jersey has insufficient

information to determine whether such drug is safe for use under such conditions,

the Department of Health of the State of New Jersey may, prior to the effective date

of the application, issue an order refusing to permit the application to become effective. e. This chapter shall not apply (1) to a drug intended solely for investigational use by experts qualified by scientific

training and experience to investigate the safety of drugs provided the drug is plainly

labeled “For investigational use only”; or (2) to a drug sold in this State at any time prior to the enactment of this subtitle

or introduced into interstate commerce at any time prior to the enactment of the Federal

Act; or (3) to any drug which is licensed under the virus serum, and toxin Act of July 1,

1902 (U.S.C.1934 ed. title 42, Chap. 4 2 ); or (4) to a drug dispensed on a written prescription signed by a physician, dentist,

or veterinarian (except a drug dispensed in the course of conduct of a business of

dispensing drugs pursuant to diagnosis by mail) if (1) such physician, dentist, or

veterinarian is licensed by law to administer such drug, and (2) such drug bears a

label containing the name and place of business of the dispenser, the serial number

and date of such prescription, and the name of such physician, dentist, or veterinarian. 1

See 21 U.S.C.A. § 355. 2

Former 42 U.S.C.A. §§ 141 to 148.